MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,366,000 | -16.9% | 85,180 | -0.7% | 0.05% | -7.0% |
| Q1 2019 | $2,848,000 | +8.9% | 85,780 | -4.7% | 0.06% | +1.8% |
| Q4 2018 | $2,615,000 | -14.2% | 89,974 | +35.7% | 0.06% | +3.7% |
| Q3 2018 | $3,049,000 | +108.5% | 66,287 | +69.5% | 0.05% | +116.0% |
| Q2 2018 | $1,462,000 | +146100.0% | 39,111 | +205747.4% | 0.02% | – |
| Q1 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -99.8% | 19 | -99.9% | 0.00% | -100.0% |
| Q4 2014 | $599,000 | -12.3% | 17,585 | -0.8% | 0.02% | -16.0% |
| Q3 2014 | $683,000 | -1.0% | 17,720 | -0.1% | 0.02% | -3.8% |
| Q2 2014 | $690,000 | -61.6% | 17,736 | -76.8% | 0.03% | -68.3% |
| Q3 2013 | $1,797,000 | -43.1% | 76,476 | -34.9% | 0.08% | -41.8% |
| Q2 2013 | $3,156,000 | – | 117,460 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,309,206 | $109,866,000 | 6.94% |
| SG Capital Management LLC | 604,159 | $20,058,000 | 3.66% |
| KESTREL INVESTMENT MANAGEMENT CORP | 232,975 | $7,735,000 | 3.57% |
| Broadfin Capital, LLC | 500,000 | $16,600,000 | 3.43% |
| Tieton Capital Management, LLC | 98,199 | $3,260,000 | 2.90% |
| SG Capital Management LLC | 350,000 | $11,620,000 | 2.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,852,064 | $94,689,000 | 1.66% |
| Broadfin Capital, LLC | 240,000 | $7,968,000 | 1.64% |
| Millrace Asset Group, Inc. | 58,302 | $1,936,000 | 1.63% |
| PURA VIDA INVESTMENTS, LLC | 300,000 | $9,960,000 | 1.42% |